Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2026 Aug 21;45:184. doi: 10.1186/s13046-026-03800-9

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma

Barbara Montico 1,#, Giorgio Giurato 2,3,#, Roberto Guerrieri 1, Francesca Colizzi 1, Annamaria Salvati 2,4, Giovanni Nassa 2,3,4, Jessica Lamberti 1,2, Domenico Memoli 2,3, Patrizia Sabatelli 5, Marina Comelli 6, Arianna Bellazzo 1, Albina Fejza 7,8, Lucrezia Camicia 7, Lorena Baboci 1, Michele Dal Bo 9, Alessia Covre 10, Tuula A Nyman 11, Alessandro Weisz 2,3,4, Agostino Steffan 1, Michele Maio 10,12, Luca Sigalotti 13, Maurizio Mongiat 7, Eva Andreuzzi 14,#, Elisabetta Fratta 1,✉,#
PMCID: PMC13495281  PMID: 42625217

Correction: J Exp Clin Cancer Res 43, 303 (2024)

https://doi.org/10.1186/s13046-025-03289-8

Following publication of the original article [1], the authors found errors in the published version of Fig. 1, specifically:

Fig. 1H – incorrect image was inadvertently uploaded. For Mel 272, the label “cytosolic proteins, n = 4” has been corrected to “n = 24”, while for Mel 593 “cytosolic proteins, n = 16” has been corrected to “n = 31”

The correct figure is presented below. The original article [1] has been corrected.

Incorrect Fig. 1

Fig. 1.

Fig. 1

Spry1KO is found associated to proteins involved in key mitochondrial functions in BRAF-mutant CM. A Summary of the experimental workflow applied to generate the protein datasets and venn diagram representing the Spry1-interacting proteins found enriched in Mel 272, Mel 593, and Mel 611 cells. B Classification of Spry1 molecular partners. C Lollipop chart showing statistically significant canonical pathways where the Spry1 interactomes are involved. The length of the lollipop indicates the enrichment value, the dot size corresponds to the number of proteins in each pathway. D Graph showing mitochondrial and cytosolic number of proteins in each of the Spry1 interactomes analysed; (* P ≤ 0.01, hypergeometric test). E IP-Western blot showing Spry1-ACK1 and Spry1-PGAM5 interaction. IgG was used as negative control. F Western blot analysis of ACK1, PGAM5 and Spry1 protein levels in cytosol and mitochondria in Mel 593 parental cells and Spry1KO clones. COX IV and β-tubulin were used as protein loading control and as mitochondrial and cytosol markers, respectively. G Western blot analysis of Spry1 protein levels in cytosol and mitochondria in Mel 272, Mel 593, Mel 611 parental cells and Spry1KO clones. COX IV and β-tubulin were used as protein loading control and as mitochondrial and cytosol markers, respectively. H TEM images of Mel 593 parental cells and their relative Spry1KO clones. The arrows indicate m, mitochondrion; N, nucleus

Correct Fig. 1

Fig. 1.

Fig. 1

Spry1KO is found associated to proteins involved in key mitochondrial functions in BRAF-mutant CM. A Summary of the experimental workflow applied to generate the protein datasets and venn diagram representing the Spry1-interacting proteins found enriched in Mel 272, Mel 593, and Mel 611 cells. B Classification of Spry1 molecular partners. C Lollipop chart showing statistically significant canonical pathways where the Spry1 interactomes are involved. The length of the lollipop indicates the enrichment value, the dot size corresponds to the number of proteins in each pathway. D Graph showing mitochondrial and cytosolic number of proteins in each of the Spry1 interactomes analysed; (* P ≤ 0.01, hypergeometric test). E IP-Western blot showing Spry1-ACK1 and Spry1-PGAM5 interaction. IgG was used as negative control. F Western blot analysis of ACK1, PGAM5 and Spry1 protein levels in cytosol and mitochondria in Mel 593 parental cells and Spry1KO clones. COX IV and β-tubulin were used as protein loading control and as mitochondrial and cytosol markers, respectively. G Western blot analysis of Spry1 protein levels in cytosol and mitochondria in Mel 272, Mel 593, Mel 611 parental cells and Spry1KO clones. COX IV and β-tubulin were used as protein loading control and as mitochondrial and cytosol markers, respectively. H TEM images of Mel 593 parental cells and their relative Spry1KO clones. The arrows indicate m, mitochondrion; N, nucleus

Footnotes

Barbara Montico and Giorgio Giurato contributed equally to this work.

Eva Andreuzzi and Elisabetta Fratta share co-last authorship.

Giorgio Giurato is deceased.

Reference

  • 1.Montico B, Giurato G, Guerrieri R, et al. Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma. J Exp Clin Cancer Res. 2025;44:53. 10.1186/s13046-025-03289-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES